(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty
Study sponsor: Atossa Therapeutics, Inc. · ATOS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2028-06Estimated
Enrollment · participants6Estimated
Source updated2026-10-09Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.